Lowering C-reactive protein independently lowers cardiac risk
The first of two important studies from the New England Journal of Medicine. This is the first time that a study has shown lowering CRP (via statins) improves cardiac outcomes independent of cholesterol level.
Earlier this year, the goal LDL (“bad” cholesterol) for those at very high risk was lowered to 70. Now it seems that targeting and monitoring CRP as well (i.e. to less than a level of 2) would be the next step in cardiac risk stratification.
Update:
JournalClub comments.
